Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • biotechwatcher biotechwatcher May 28, 1998 3:21 PM Flag

    report

    Report looks good. They are trying to put a good
    spin on the HIV protease inhibitor. No apparent
    progress with the HepC program with Lilly. Rumor has it
    that finding a protease inhibitor is extremely
    difficult, and some Pharma companies have already dropped
    out or are focusing on other targets (eg. helicase
    and replicase). The recent allowances for nerve
    growth cpds bode well. In this way they have established
    a niche where other companies focus on the protein
    factors themselves, where there are likely to be patent
    fights. The issues of concern for theses molecules are
    potency and bioavailability, but at least they look
    interesting.

 
VRTX
140.30+3.31(+2.42%)Aug 4 4:00 PMEDT